Volume 5, Number 3—June 1999

Perspective

The Cost Effectiveness of Vaccinating against Lyme Disease

Martin I. Meltzer , David T. Dennis, and Kathleen A. Orloski

Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 1

Figure 1. Decision tree to model the cost effectiveness of vaccinating a person against Lyme disease.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.